Haemonetics Corporation
Haemonetics Corporation (HAE) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Haemonetics Corporation (HAE) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Aug 12, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More HAE filings
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 4
Filed Nov 3, 2026
- 8-K
Filed Oct 8, 2026
- 8-K
Filed Aug 18, 2026
- S-8
Filed Aug 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.